Moreover, in Alzheimer’s disease and Parkinson’s disease models, adiponectin crosses the blood-brain barrier to reduce inflammation and oxidative stress (Ng and Chan, 2017; Polito et al., 2020; Formolo et al., 2022). Here, ADIPOQ is linked to early-onset autosomal dominant Alzheimer disease.